Are Options Traders Bullish on ALDR?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About ALDR

Alder BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. Alder’s lead clinical candidate, ALD403, inhibits a well validated molecule shown to trigger migraine attacks, calcitonin gene-related peptide (CGRP), and is currently undergoing Phase 2b clinical testing for the treatment of chronic migraines. Alder has initiated a pivotal clinical trial for the treatment of frequent episodic migraine and plans to initiate additional advanced clinical trials for ALD403 in frequent episodic and chronic migraine in 2016. Alder’s second program, ALD1613, which targets adrenocorticotropic hormone (ACTH) is undergoing Investigational New Drug (IND)-enabling preclinical studies with the initiation of clinical trials in Congenital Adrenal Hyperplasia or Cushing’s disease planned for 2016. Finally, clazakizumab, previously known as ALD518, is designed to block the pro-inflammatory cytokine IL-6 and has completed a Phase 2b clinical trial. Alder is seeking a partner or other strategic alternatives for clazakizumab.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ALDR is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 283.8 M 2.83842E+08 202 202 0.06% 0.000554427 326 K 326244
EQWS Invesco Russell 2000 Equal Weight ETF 20.8 M 2.08E+07 1,977 1977 0.02% 0.00022 5 K 4646
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 347 347 0.02% 0.00019751 316 K 315614
IBB iShares Nasdaq Biotechnology Index Fund 8.0 B 8.00963E+09 191 191 0.13% 0.0013 10.4 M 1.04074E+07
ITOT iShares Core S&P Total U.S. Stock Market ETF 15.3 B 1.53181E+10 3,420 3420 0.0% 0 478 K 478211
IWM iShares Russell 2000 ETF 44.5 B 4.44813E+10 2,022 2022 0.04% 0.0004 17.7 M 1.76687E+07
IWN iShares Russell 2000 Value ETF 9.4 B 9.39433E+09 1,373 1373 0.01% 0.0001 1.4 M 1389580
IWO iShares Russell 2000 Growth ETF 9.0 B 8.98678E+09 1,240 1240 0.06% 0.0006 5.7 M 5697710
IWV iShares Russell 3000 ETF 8.4 B 8.38911E+09 3,006 3006 0.0% 0 266 K 266170
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.9 B 1.9E+09 1,029 1029 0.01% 0.000117397 217 K 217243
PRFZ Invesco FTSE RAFI US 1500 Small-Mid ETF 1.9 B 1.9252E+09 1,447 1447 0.02% 0.00021 407 K 406558
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.4 B 1.3799E+09 1,904 1904 0.01% 5.2E-05 71 K 70575
UBIO Proshares UltraPro Nasdaq Biotechnology 28.8 M 2.87594E+07 196 196 0.03% 0.000260232 25 K 24747
URTY ProShares UltraPro Russell2000 108.8 M 1.08826E+08 2,033 2033 0.01% 6.87439E-05 25 K 25269
UWM ProShares Ultra Russell2000 162.8 M 1.62825E+08 2,033 2033 0.02% 0.000150616 52 K 52409
XBI SPDR Series Trust SPDR S&P Biotech ETF 4.4 B 4.43077E+09 126 126 0.58% 0.00581434 25.3 M 2.532208E+07
FAD First Trust Multi Cap Growth AlphaDEX Fund 192.9 M 1.9294E+08 675 675 0.02% 0.0002 39 K 38588
FYC First Trust Small Cap Growth AlphaDEX Fund 405.8 M 4.05802E+08 262 262 0.11% 0.0011 446 K 446382
FYX First Trust Small Cap Core AlphaDEX Fund 632.2 M 6.32175E+08 526 526 0.06% 0.0006 379 K 379305

Wait, Before You Leave...